Esperion Therapeutics Inc (NASDAQ: ESPR): Hunting Genuine Value In Market Debris
Currently, there are 196.66M common shares owned by the public and among those 194.72M shares have been available to trade. The company’s stock has a 5-day price change of 28.06% and -40.68% over the past three months. ESPR shares are trading -52.27% year to date (YTD), with the 12-month market performance down to -54.15% lower. […]
Is Esperion Therapeutics Inc (NASDAQ: ESPR) Back In The Buying Zone?
Currently, there are 196.66M common shares owned by the public and among those 194.72M shares have been available to trade. The company’s stock has a 5-day price change of 16.40% and -52.17% over the past three months. ESPR shares are trading -58.70% year to date (YTD), with the 12-month market performance down to -64.92% lower. […]
Esperion Therapeutics Inc (NASDAQ: ESPR) Is Getting Increasingly Hard To Ignore
Currently, there are 196.66M common shares owned by the public and among those 194.72M shares have been available to trade. The company’s stock has a 5-day price change of -23.91% and -57.05% over the past three months. ESPR shares are trading -63.69% year to date (YTD), with the 12-month market performance down to -60.84% lower. […]
Assessing Whether Esperion Therapeutics Inc (NASDAQ: ESPR) Is Over- Or Undervalued
Esperion Therapeutics Inc (ESPR) concluded trading on Wednesday at a closing price of $0.87, with 5.97 million shares of worth about $5.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.10% during that period and on May 07, 2025 the price saw a […]
Set Your Sights On Esperion Therapeutics Inc (NASDAQ: ESPR)’S Upside Potential
Esperion Therapeutics Inc (ESPR) concluded trading on Wednesday at a closing price of $1.00, with 5.24 million shares of worth about $5.24 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -52.41% during that period and on April 30, 2025 the price saw a […]
Technical Outlook And Game Plan For Esperion Therapeutics Inc (NASDAQ: ESPR)
Esperion Therapeutics Inc (ESPR) concluded trading on Wednesday at a closing price of $0.95, with 4.92 million shares of worth about $4.67 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -53.47% during that period and on April 23, 2025 the price saw a […]
Institutional Exposure To Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.61, with 4.62 million shares of worth about $12.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.35% during that period and on Wednesday the price saw a loss of […]
Esperion Therapeutics Inc. (NASDAQ: ESPR) Stock In Prove Me State
Esperion Therapeutics Inc. (ESPR) concluded trading on Thursday at a closing price of $2.66, with 2.99 million shares of worth about $7.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.86% during that period and on Thursday the price saw a gain of […]
Do Esperion Therapeutics Inc. (NASDAQ: ESPR) Fit In A Value Investing Philosophy?
Currently, there are 170.42M common shares owned by the public and among those 169.06M shares have been available to trade. Insiders at the company have transacted a total of 31 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 17 of these insider trades were purchases, […]
Growth Story Still Intact For Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc. (ESPR) concluded trading on Wednesday at a closing price of $2.14, with 6.62 million shares of worth about $14.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 26.63% during that period and on Wednesday, January 31 the price saw a […]